- Home
- TAOP vs TCBP Comparison
TAOP vs TCBP Comparison
Compare TAOP & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- TCBP
- Stock Information
- Founded
- TAOP 1993
- TCBP 2013
- Country
- TAOP China
- TCBP United Kingdom
- Employees
- TAOP N/A
- TCBP N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TAOP Technology
- TCBP Health Care
- Exchange
- TAOP Nasdaq
- TCBP Nasdaq
- Market Cap
- TAOP 2.5M
- TCBP 3.0M
- IPO Year
- TAOP N/A
- TCBP 2022
- Fundamental
- Price
- TAOP $0.36
- TCBP $0.68
- Analyst Decision
- TAOP
- TCBP
- Analyst Count
- TAOP 0
- TCBP 0
- Target Price
- TAOP N/A
- TCBP N/A
- AVG Volume (30 Days)
- TAOP 750.2K
- TCBP 3.0M
- Earning Date
- TAOP 09-05-2024
- TCBP 11-29-2024
- Dividend Yield
- TAOP N/A
- TCBP N/A
- EPS Growth
- TAOP N/A
- TCBP N/A
- EPS
- TAOP 0.50
- TCBP N/A
- Revenue
- TAOP $42,636,173.00
- TCBP N/A
- Revenue This Year
- TAOP N/A
- TCBP N/A
- Revenue Next Year
- TAOP N/A
- TCBP N/A
- P/E Ratio
- TAOP $0.57
- TCBP N/A
- Revenue Growth
- TAOP 37.49
- TCBP N/A
- 52 Week Low
- TAOP $0.33
- TCBP $0.56
- 52 Week High
- TAOP $2.01
- TCBP $138.00
- Technical
- Relative Strength Index (RSI)
- TAOP 32.81
- TCBP 23.01
- Support Level
- TAOP $0.33
- TCBP $1.05
- Resistance Level
- TAOP $0.51
- TCBP $1.25
- Average True Range (ATR)
- TAOP 0.04
- TCBP 0.22
- MACD
- TAOP -0.00
- TCBP 0.06
- Stochastic Oscillator
- TAOP 20.00
- TCBP 10.36
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.